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1. Introduction 
In the evaluation of Attention Deficit Hyperactivity Disorder (ADHD), medical and 
behavioral problems related to sleep are important to consider. A relationship between 
ADHD and sleep has been acknowledged for some time. Sleep disturbances were among 
criteria for ADHD diagnosis in the past and rating scales for ADHD included items related 
to sleep disturbance (American Psychiatric Association [APA], 1987; Conners, et al. 1998, 
1998). While our knowledge about the relationship between ADHD and sleep problems has 
improved in recent years, it remains challenging to tease apart the effect of insufficient or 
poor quality sleep on attention, alertness, learning and behavior and what might be due to a 
primary ADHD, mood or behavior problem (Simonds, 1984). This interface of mental health 
disorder and sleep disorder is a challenge many clinicians face in practice. Medical, mental 
health, behavioral and psychosocial factors can directly affect the quality and duration of 
sleep. Poor sleep, in turn, can have effects on daytime functioning and health. In addition, 
such medical and mental health problems can have direct effects on attention, learning and 
behavior. Sorting out the important contributing factors during a comprehensive evaluation 
can be challenging due to sleep and ADHD problems commonly co-occurring. The primary 
purpose of this chapter is to highlight the importance of including the evaluation of sleep as 
a part of the assessment of disorders such as ADHD because the best management for the 
individual patient depends on the accuracy of the diagnostic evaluation.  
As discussed in other chapters in this book, ADHD is a common disorder that presents in 
childhood. It is estimated to affect 5-10% of school-age children and adolescents (Committee 
on Quality Improvement, 2000). Symptoms such as distractibility, forgetfulness and failure 
to complete work typify inattentive-type ADHD. Impulsivity, over activity and being 
fidgety are among symptoms that are common for individuals with hyperactive-impulsive 
type ADHD. Having symptoms that meet criteria for both subtypes is required for a 
diagnosis of combined-type ADHD. DSM-IV criteria require that symptoms have onset 
before age 7 years (APA, 2000); however, the symptoms of inattentive-type ADHD are often 
subtle and not recognized until later school years when the academic curriculum is more 
challenging and requires greater executive functioning skills to keep pace and do well. In 
addition, the symptoms of ADHD are non-specific on their own and can be related to other 
factors, contexts and diagnoses. Due to this, it can be challenging to determine if the pattern 
of an individual’s behavior is best described by the diagnosis of ADHD.  
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Sleep problems occur commonly, from infancy through childhood and adolescence and are 
related to daytime behavioral concerns. For instance, bedtime resistance and night waking 
are common among toddlers and preschoolers, affecting 30% or more. A significant 
relationship between sleep problems and parent-reported concerns about internalizing and 
externalizing behaviors has been demonstrated for this age group (Reid, 2009; Mindell, 
2010). Among school-age children, 11 to 37% have problems with sleep and many describe 
feeling sleepy during the day (Sleep in America Poll Summary of Findings [SAP], 2004). 
Studies of adolescents and the 2006 National Sleep Foundation Poll of US adolescents 
nationwide also describe a high prevalence of sleep problems at this age (Owens, 2005; SAP, 
2006). Forty-five percent of adolescents report short night time sleep durations and more 
than half report feeling tired or sleepy during the day. Many adolescents also report feeling 
unhappy and that they are not getting enough sleep.  
In this chapter, we will discuss: the neurobiological aspects of ADHD and sleep; typical 
patterns of normal sleep for children and expected age-related changes; common sleep 
disorders and their effects on daytime functioning with particular attention to ADHD; sleep 
characteristics for children with ADHD and the effects of medications; and the importance 
of screening for sleep concerns in the evaluation and management of ADHD.  
2. Neurobiology 
2.1 Neurobiology of ADHD 
To review our current understanding about the overlap of ADHD and sleep from a 
neurobiological perspective, we will briefly review key concepts for ADHD, and sleep in 
this section. Although the pathophysiology of ADHD is quite complex and likely results 
from a combination of multiple factors, genetic and environmental variables have been 
identified as possible contributing components (Faraone, 1998). Anatomical studies have 
isolated abnormalities in brain regions associated with cognition, executive functioning and 
behaviors consistent with ADHD (Dahl, 1996). Functional MRI (fMRI) studies have similarly 
demonstrated abnormal activation in these areas, including the prefrontal cortex, anterior 
cingulate gyrus and thalamus (Durston, 2003; Rubia et al., 2011). Gross anatomic studies 
have demonstrated a lower total brain volume in children with ADHD (Curatolo et al., 2009; 
Makris et al., 2009; Tripp, 2009). Additionally, decreased size of the right frontal lobe (RFL), 
corpus callosum, striatum and cerebellum have been observed in children and adolescents 
with ADHD (Curatolo et al., 2009; Makris et al., 2009; Tripp, 2009). The areas found to be 
different in ADHD are those which support emotion and higher brain functions including 
executive function and attention (Makris et al., 2009). Abnormalities observed in the 
cerebrum and cerebellum have been found to persist with advancing age, whereas, 
abnormalities in the caudate normalize with age (Curatolo et al., 2009; Konrad & Eickhoff, 
2010).  
These anatomical studies and elucidating the mechanisms of stimulant medications used to 
treat ADHD, have helped to further our understanding of the neurobiological basis of this 
condition. ADHD is associated with catecholamine dysregulation, specifically related to 
dopamine and norepinephrine (Curatolo et al., 2009; Faraone, 1998, 2005; Gonon, 2009; 
Makris et al., 2009; Rosa-Neto et al., 2005; Swanson, 2000; Tripp, 2009). The dysregulation of 
dopamine in ADHD has been the focus of much inquiry. One neurophysiologic finding 
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characteristic of ADHD, which is thought to underlie some ADHD symptoms, is an atypical 
response to reward (Tripp, 2009; Nigg, 2005). Dopamine is thought to be an important 
component of the neural system of reward (Tripp, 2009), as well as for ADHD. The brain 
regions believed to be important in children and adults with ADHD, in which gross 
anatomic differences have been demonstrated, are rich in dopamine signaling (Curatolo et 
al., 2009; Makris et al., 2009; Tripp, 2009). Additionally, genes associated with ADHD are 
involved in the regulation of extracellular dopamine (Faraone, 1998, 2005; Swanson, 2000). 
The therapeutic mechanism of stimulant treatment is related to dopamine and other 
catecholamines, and stimulant treatment is most often used in ADHD (Del Campo et al., 
2011; Rosa-Neto et al., 2005; Rubia et al., 2011). Methylphenidate exerts a therapeutic effect 
for ADHD by increasing the extracellular availability of dopamine (and norepinephrine) by 
blocking the reuptake of dopamine via transporter binding (Del Campo et al., 2011; Tripp, 
2009; Faraone, 1998). Amphetamines work similarly to methylphenidate, but also increase 
the release of dopamine and norepinephrine and decrease the catabolic activity of 
monoamine oxidase (Del Campo et al., 2011). PET imaging studies have shown acute 
increases in extracellular dopamine with methylphenidate administration (Rosa-Neto et al., 
2005). Thus, the stimulant medications are thought to correct an underlying deficit related to 
dopamine regulation and availability. 
Additional catecholamines, including norepinephrine and serotonin are thought to play a 
role in ADHD; however the roles of these neurotransmitters are less well understood 
(Zimmer, 2009; Del Campo et al., 2011). Norepinephrine neurons are mainly located in the 
locus cerulus, part of the reticular activating system, which is thought to be an important 
center in regulating attention and arousal (Owens, 2005). As discussed above, extracellular 
norepinephrine levels are increased with the use of psychostimulant medications (Del 
Campo et al., 2011). Non-stimulant medications, atomoxetine and alpha-agonists, effectively 
increase extracellular norepinephrine levels and have also been successfully used in the 
treatment of ADHD. A serotonin transporter has been associated with ADHD (Faraone, 
2005), although serotonin’s role in ADHD has not yet been clarified. 
2.2 Neurobiology of sleep 
The neurobiology of sleep has also been a focus of study in recent years, and has become 
much better understood. As reviewed below, sleep has two distinct stages, non-rapid eye 
movement (non-REM) and rapid-eye movement (REM) that alternate in cycles through the 
night. non-REM sleep is a period of relatively low brain activity, although the brain’s 
regulatory capacity is still active, and body movements are preserved. non-REM sleep can 
be further divided into stages 1-3 by the ‘deepness’ of the sleep, stage 3 being the deepest. 
REM sleep is a period of desynchronized cortical activity, high metabolic rate, lack of 
muscle tone and episodic bursts of rapid eye movements (Mindell, 2010). Arousal opposes 
sleep in the sleep-wake cycle, and the daily shift between these states requires a fine-tuned 
system of neural interactions (Dahl, 1996). Multiple, different neural systems have been 
implicated in the control of the waking state (Lu, 2010; Espana, 2004).  
A 2-process model has been proposed to explain the interactions of different biologic 
mechanisms of sleep. The homeostatic process, which regulates length and depth of sleep, 
interacts with the endogenous circadian rhythm system, which influences the internal sleep 
organization and the timing and duration of daily sleep-wake cycles (Owens, 2005; Pace-
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Schott & Hobson, 2002). The homeostatic process or sleep drive is dependent upon the 
quality and quantity of previous sleep, as well as the period of time spent awake; the sleep 
drive increases with longer waking periods, and poorer sleep quality or duration (Owens, 
2005). The circadian rhythm is synchronized with a 24 hour day, with predictable periods of 
increasing arousal and sleepiness, which are linked to ambient light exposure (Owens, 
2005). The light-dark cycle is a powerful zeitgeber or cue that entrains the circadian clock to 
the 24-hour day. The suprachiasmatic nucleus of the hypothalamus responds to these cues 
by influencing the production of melatonin. Under typical circumstances, as one nears the 
usual dark period, melatonin production increases and facilitates sleep onset. In addition to 
environmental cues which help to keep the circadian clock on track, genetics is also thought 
to play a role. Individuals appear to have a genetic propensity to be a “lark” (sleep-wake 
cycle set earlier) or a “night owl” (sleep-wake cycle set later).  
The ascending arousal system consists of multiple neurotransmitters and produces cortical 
arousal through two pathways. The dorsal route ascends through the thalamus, and the 
ventral route through the hypothalamus and basal forebrain (Fuller, et. al, 2006). The 
arousal system is opposed by the ventrolateral preoptic nucleus (VLPO), which is active 
during sleep (Fuller, et. al, 2006). The VLPO initiates sleep after input from the circadian 
rhythm, and homeostatic process (sleep drive) (Pace-Schott & Hobson 2002).  
Many neurotransmitters have been implicated in the regulation of behavioral state in the 
sleep-wake cycle. During wakefulness and rapid eye movement (REM) sleep, cholinergic 
neurons in thalamus, hypothalamus & dorsal midbrain activate the thalamocortical 
signaling to produce fast cortical rhythms (Espana, 2004; Lu, 2010). In non-REM sleep, 
however, these neurons are relatively inactive (Espana, 2004; Lu,, 2010). Neurons in the 
locus ceruleus (mainly producing norepinephrine) are active during waking, less active 
during non-REM sleep and demonstrate almost no activity during REM sleep (Espana, 
2004). Norepinephrine induces cortical activation & wakefulness, especially in the setting of 
stress (Espana, 2004; Lu, 2010). Similarly, neuronal histamine is found in the 
tuberomammillary nucleus, which is active during wakefulness, with less activity during 
non-REM sleep and even less during REM sleep (Espana, 2004). Histamine promotes 
wakefulness, especially at the time of waking and during conditions that require high 
behavioral arousal (Espana, 2004). Serotonin has also been connected to the regulation of 
behavioral state. The dorsal raphe nucleus is an important source of serotonin, and has 
(similarly to other aminergic neurons) been found to be most active during wakefulness, less 
so during non-REM sleep and virtually inactive during REM sleep (Espana, 2004). 
Orexin/hypocretin neurons are most active during wakefulness, particularly during periods 
of increased arousal or locomotor activity (Espana, 2004; Lu, 2010). Orexin/hypocretin 
neurons appear to be inhibited by the amines, and are at their highest level at the end of the 
day, possibly working to oppose the increasing sleep drive (Espana, 2004). 
Dopamine is thought to have wake-promoting properties, but its’ role in the sleep-wake 
cycle has been difficult to understand due to the lack of obvious change in dopaminergic 
firing rate throughout the sleep-wake cycle (Espana, 2004; Lu, 2010). Yet, extracellular levels 
of dopamine are elevated during wakefulness and dopamine receptor agonists increase 
waking while reducing non-REM and REM sleep (Espana, 2004). It has also been noted that 
patients using dopamine antagonists, such as antipsychotics, and patients with Parkinson’s 
Disease (deficient in dopamine) are often sleepy (Espana, 2004; Lu, 2010). This supports 
likely wake-promoting properties of dopamine.  
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Recently, there has been increasing evidence regarding the neurobiological overlap of sleep 
and ADHD (Owens, 2005). A proposed relationship for sleep disruption and ADHD is an 
altered pattern of melatonin secretion or responses to environmental cues such as light. 
Alternatively, common anatomical pathways may provide the link between sleep and 
ADHD. The reticular activating system and prefrontal cortex have been implicated in the 
regulation of both attention/arousal and sleep (Owens, 2005). The thalamus is thought to 
play a role in working memory and behavioral inhibition abnormalities in ADHD, and in 
the regulation of non-REM sleep (Owens, 2005). Additionally, aberrations in dopamine and 
norepinephrine signaling have been identified in both sleep disturbances and ADHD 
(Owens, 2005; Espana, 2004). The role of other neurotransmitters important in sleep such as 
histamine and acetylcholine in ADHD, if any, have not yet been identified. Although we do 
not fully understand the relationship between sleep and ADHD, there appears to be 
substantial overlap. We will further explore this relationship throughout this chapter.  
3. Typical sleep in children and adolescents 
As noted above, sleep is a complex process described as a rapidly reversible state of reduced 
responsiveness to the environment. Through basic processes inherent in sleep, our 
memories are consolidated, growth is optimized, and the next day we hopefully feel less 
sleepy, have restored energy and attention and the prospect of better learning and mood. 
During childhood and adolescence, sleep durations and patterns and other aspects such as 
associated behaviors change with normal development. Here we briefly review the 
architecture of sleep and how the patterns of sleep-wake cycles change with age (Owens, 
2005; Mindell, 2010). 
The architecture of sleep involves ultradian rhythms or cycles that consist of two sleep 
stages, non-REM and REM sleep. The duration of these ultradian cycles changes with 
development, being about 50 minutes in infancy and lengthening to adult levels (90-120 
minutes) by school-age. It is typical for individuals to have a brief arousal at the end of these 
cycles, about 4 to 6 times during the sleep period. Non-REM sleep includes stage 1 or 
transitional sleep from which a person can be readily aroused, stage 2 which accounts for 
the majority of non-REM sleep and stage 3 or slow wave sleep (SWS), from which it is more 
difficult to arouse. REM sleep is characterized by an active EEG pattern and bursts of eye 
movements are a hallmark of this stage that includes dreaming. Non-REM sleep is more 
predominant early in the sleep period, about the first third, and REM sleep accounts for a 
greater percentage of sleep in the last third. Important biological functions are attributed to 
each sleep stage, for instance growth and neuroendocrine function for non-REM sleep and 
memory consolidation and learning for REM sleep. The stages of non-REM sleep develop in 
infancy and the relative percentage of SWS peaks during early childhood and declines by 
adolescence. In infancy, REM sleep accounts for about 50% of sleep. This declines during 
childhood and reaches adult levels (about 25-30% of sleep) by adolescence (Mindell, 2010).  
The overall duration and pattern of sleep changes with age and development (Iglowstein et 
al., 2003). Other factors also influence sleep patterns including (among others) child health 
and temperament, activities and regularity of family routines and cultural expectations. 
Typically, infants and toddlers sleep 11-13 hours across day and nighttime sleep and this 
declines to 9-10 hours by school age. While adolescents might self-describe needing less 
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sleep, typical adolescents do best with about 9 to 9.25 hours. Naps account for 3-4 hours of 
total sleep for infants, distributed as 2-4 a day and decline to 1 nap by about 18 months of 
age. Napping continues into toddler to preschool years; about 50% of children at age 3 years 
continue to nap, 25% at 4 years and 15% at 5 years. At school age, children are typically 
quite alert during the day and have little daytime sleepiness or napping unless driven by 
cultural preferences. At this age, daytime sleepiness would be a symptom deserving of 
further investigation, particularly in the context of learning, attention and behavioral 
problems. However, recent studies in this age group suggest that even in the absence of 
overt sleepiness, daytime behavioral concerns may indicate insufficient sleep duration or 
quality. By adolescence, the normal physiological phenomena of later sleep-wake cycles, 
called delayed sleep phase, typically predominates such that bedtimes and sleep onset times 
drift later, often by several hours. Concurrent early school start times set the stage for 
insufficient duration of night time sleep, typically 7 to 7.5 hours for many adolescents. In 
addition, teenagers have more variability in their sleep-wake patterns as they try to pay 
back their sleep debt on the weekend. Such irregular schedules add to the risk of sleep 
problems and chronic sleep deprivation affects several aspects of daytime functioning 
including attention, learning, and mood. Over half of adolescents report that they feel tired 
and sleepy during the day and about 25% reported falling asleep in school at least once a 
week (SAP, 2006). Sometimes caffeine will be used in the attempt to stay alert and result in 
further delay of sleep onset when consumed too close to bedtime. 
It is also important to recognize that the ability of parents to report a sleep problem for their 
child also appears to be age-related. According to a recent national poll, about 16% of 
adolescents report having sleep problems; however, only about 7% of parents report 
problems with sleep for their teenagers (SAP, 2006). Parents of younger children may be 
more likely to be aware of the characteristics of their children’s sleep and bring it up as a 
concern but not uniformly. Thus, it is important to inquire with children and adolescents 
directly as well as the parent when evaluating for sleep problems (Owens, 2000). 
4. Sleep disorders 
In the following section, we describe the medical and behavioral characteristics of several 
sleep disorders and review associated studies that examine daytime functioning, 
particularly related to attention, learning and behavior. The majority of pediatric research 
thus far has centered on the first two conditions described, sleep disordered breathing and 
restless legs or periodic limb movement disorder.  
4.1 Sleep Disordered Breathing 
The term sleep disordered breathing (SDB) represents a spectrum of disorders which 
includes at the severe end, obstructive sleep apnea (OSA). The SDB spectrum also includes 
other conditions such as, primary snoring (airflow causes airway vibration but no other 
observable abnormality), upper airway resistance syndrome (hypoventilation and increased 
intrathoracic pressure resulting in fragmented sleep but without frank apneas, or the 
cessation of breathing), and apnea due to central nervous system processes. OSA is marked 
by snoring and apnea, and accompanied by hypoxemia or oxygen desaturation. To 
determine whether the symptom of snoring is associated with periods of apnea or hypopnea 
(low airflow and associated oxygen desaturation) a polysomnogram or sleep study is 
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needed. OSA is typically marked by repeated and sometimes prolonged periods of reduced 
or no airflow resulting in low oxygen delivery (hypoxia) to the brain and disrupted sleep 
(Mindell, 2010).  
About 30% of children snore and about 3-4% have OSA. The parents of children with OSA 
might report hearing loud or heroic snoring and pauses in breathing, snorts or gasps. 
However, the symptoms of OSA may be less pronounced. Children with OSA may present 
with restless sleep, nocturnal sweating, unusual positions while sleeping (e.g., neck 
extended), morning headache and dry mouth. One risk for OSA emerges from processes of 
normal development. During preschool to early school age, children experience a relative 
increase of lymphoid tissue including tonsils and adenoids. When this increase outpaces the 
growth of the normal airway, a risk of airway obstruction occurs especially during periods 
of lower muscle tone, e.g., during sleep. Other factors also increase the risk of obstruction 
during breathing and include (among others), chronic nasal congestion, lower muscle tone 
due to medical conditions, oropharyngeal features, and obesity (Mindell, 2010; Hodges, 
2011).  
Growing concerns about SDB and the effect on day daytime functioning have fueled 
investigations about the relationship between ADHD and SDB in children presenting with 
one or the other condition or both. A number of methods have been used. Surveys have 
been conducted in general populations of children or in individuals suspected to have these 
specific disorders. Studies have also assessed for relationships between ADHD and SDB 
concurrently and prospectively as well as, before and after surgical intervention to remove 
tonsils and adenoids. Parents of children with an ADHD diagnosis were more likely to 
endorse symptoms of habitual snoring for their children than parents of non-snorers; 22% 
versus 12%, respectively (Chervin, 2002). In addition, those children who were rated as 
having high SDB scores were more likely to describe ADHD symptoms of inattention and 
hyperactivity (Chervin, 1997). In a study of children ages two to thirteen years (at 
enrollment), those endorsed as habitual snorers at baseline were more likely to have 
hyperactive behavior four years later (Chervin, 2005). Early case studies reported ADHD 
symptoms in children referred for evaluation of SDB symptoms (Guilleminault C., 1981). In 
a study by Dillon et al, of children five to twelve years of age scheduled for 
adenotonsillectomy, nearly 37% had evidence of ADHD and disruptive behavior disorder 
(including oppositional and conduct disorder) and about 28% had ADHD (Dillon, 2007). 
This study also assessed behavioral outcomes after adenotonsillectomy. Fifty percent of the 
children who met criteria for ADHD at baseline before adenotonsillectomy no longer did so 
after surgery (Dillon, 2007). In a review of sixteen studies, parents who reported higher SDB 
symptoms for their children also reported they had higher inattention and hyperactivity 
symptoms (Hodges, 2008; Cortese, 2009). Thus, there is substantial evidence supporting a 
relationship between ADHD and SDB.  
In children with SDB, excessive daytime sleepiness is a common symptom that affects 
functioning related to attention and activity. Whereas tired or sleepy adolescents may report 
more problems staying awake, younger sleepy children may present with hyperactive and 
agitated behaviors (Hodges, 2011). In school-age children with SDB, time to fall asleep on 
structured nap tests (mean sleep latency test) was associated with the severity of SDB before 
adenotonsillectomy. One year after surgery; however, when SDB symptoms had improved, 
this association was no longer observed (Chervin, 2006; Gozal, 2001). In a meta-analysis 
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review of 16 studies, daytime sleepiness was among the variables associated with ADHD. A 
recent study also found a significant relationship between daytime sleepiness and 
inattentive type ADHD (Cortese, 2009; Mayes, 2009). Other studies have demonstrated 
similar neurobehavioral outcomes related to SDB and/or excessive daytime sleepiness 
including impaired attention, tests of executive functioning, behavioral regulation and 
scores of intellectual functioning in some studies (Beebe, 2005; Owens, 2005; Beebe, 2004; 
Gottlieb, 2004). In many children with SDB, adenotonsillectomy results in improvements in 
neurobehavioral outcomes, and improvement in sleepiness is felt to play a role. 
There does not appear to be a clear “dose-response” relationship between SDB and ADHD. 
In a community-based study, parents rated their 5-7 year old children for ADHD symptoms 
and a subset of the children underwent polysomnogram. OSA was observed for 26% of the 
children with mild ADHD symptoms versus 5% for those with severe ADHD or no ADHD 
concerns. This study suggested that SDB might lead to mild ADHD symptoms but not 
explain more severe ADHD symptoms (O’Brien, 2003). Chervin suggests that the 
relationship between ADHD and SDB in at-risk children may be due to more subtle aspects 
of disordered breathing (Chervin, 2005). The mechanisms by which SDB and OSA in 
particular may relate to neurobehavioral sequelae have been proposed and involve the 
effect of sleep disturbance on the prefrontal cortex, sleep fragmentation, hypoxia, and 
hypercarbia (Beebe, 2005; Hodges, 2011) . The relationship of such core factors with 
individual variables of risk are under investigation. Important individual variables include 
resilience, environmental context and demands, and the progression of these over time with 
development.  
As noted above, there is substantial overlap between brain areas that regulate sleep, arousal 
and attention raising the possibility that sleep disruption may have direct effects on central 
nervous system functioning. In addition, sleep disruption during development suggests the 
possibility that structures such as the prefrontal cortex may sustain longer term 
neuroanatomic or functional alterations as a result of early sleep problems. Prospective 
studies will provide important contributions regarding the relationship between ADHD 
symptoms and SDB and these are ongoing currently.  
4.2 Restless leg syndrome and periodic limb movement disorder 
Restless legs syndrome (RLS), periodic limb movements of sleep (PLMS) and periodic limb 
movement disorder (PLMD) are overlapping conditions that may occur separately or 
together and affect sleep quality. There is evidence of a genetic basis for RLS with PLMS 
involving chromosome 6p.(Picchietti, 2008) Restless legs syndrome is a diagnosis made 
based on presenting clinical symptoms such as uncomfortable sensations (e.g,. feeling things 
crawling or tingling) and the urge to move, both typically involving the lower limbs. RLS 
symptoms usually occur while sitting or lying down, toward evening hours, and the 
symptoms are typically relieved by movement. In children, the presentation of symptoms 
may be more variable and described differently, such as “shark bites” or “growing pains” 
for some children (Rajaram, 2004). Specific criteria for RLS were published in 2003 by NIH 
(Allen, 2003). While first observed in adults, RLS has been recognized in children for over 
fifteen years and is estimated to occur in about 2% of children (Walters, 1994; Picchietti, 
1998; Pichietti, 2007; Garcia-Borreguero, 2006; Picchietti, 2008).  
www.intechopen.com
 
ADHD and Sleep Problems in Children  
 
69 
PLMS are brief, repetitive and regular stereotyped jerks during sleep, typically occurring at 
the lower extremities and lasting up to 5 seconds. PLMD requires a polysomnogram to 
make a diagnosis which requires five or more characteristic movements per hour (criteria 
for children and adolescents), associated with sleep disturbance (e.g., arousal) or effects on 
daytime functioning (e.g., fatigue), and no other primary sleep disorder reason for the 
PLMD. The prevalence of PLMD in the general population is not known. However, based 
on survey information, PLM symptoms are thought to affect about 8-12% of children 
(Picchietti, 2008). There is evidence that altered dopaminergic central nervous system 
functioning underlies RLS and PLMD for many individuals. In addition, MRI and autopsy 
studies have identified lower iron stores in the striatum and other central nervous system 
areas for adults affected with RLS or PLMD. Further, serum ferritin <50 ng/ml has been 
associated with RLS symptoms or findings of PLMD and iron supplementation has been 
demonstrated to improve symptoms. Therefore, iron deficiency may be a treatable medical 
risk factor for RLS, PLMS and PLMD particularly associated with growing children, women 
during pregnancy and for individuals with chronic medical conditions (renal disease and 
leukemia) (Konofal, 2007; Mindell, 2010).  
RLS and PLMD have been associated with daytime symptoms of ADHD. In a study of 143, 
two to eighteen year-old children attending child psychiatry or general pediatric clinics, 
parents indicated PLMS might be related to ADHD symptoms (Chervin, 1997). In a 
questionnaire study of 830 children two to thirteen years of age, about 4% of parents 
endorsed PLM symptoms for their children (Chervin, 2001). Picchietti and others looked at 
the occurrence of PLMD for children with or without ADHD symptoms. In their study, 26% 
of children with ADHD symptoms had PLMD, compared to 5% of children who did not 
have ADHD symptoms (Picchietti, 1998). In a study comparing children referred for 
clinically defined ADHD versus two other groups, those identified as at risk for ADHD 
from a community survey and children without ADHD, those with clinically determined 
ADHD had higher PLMs than the other groups suggesting a greater risk for more active and 
disrupted sleep (O’Brien, 2003). In addition, in children with ADHD, serum ferritin less than 
12 ng/ml was more prevalent in children with RLS symptoms (Oner, 2007). Thus, RLS, 
PLMS and PLMD appear to be related to daytime ADHD symptoms; however, but further 
work is needed to clarify the relationship and the role of iron specifically in the etiology and 
management.  
4.3 Other sleep disorders 
In the following section, other sleep disorders are described that affect sleep quality and/or 
duration but have fewer studies related to daytime behavioral consequences in children and 
adolescents. This is followed by a section describing the consequences of insufficient sleep in 
general. 
4.3.1 Behavioral insomnia of childhood 
Behavioral insomnia of childhood, the difficulty initiating and/or maintaining sleep due to 
a behavioral etiology, is very common, with a prevalence of 10-30%. It is more often 
encountered in young children (Moore & Meltzer, 2008). There are 2 types of Behavioral 
Insomnia of Childhood: Sleep Onset Association; and Limit Setting. Sleep Onset Association 
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type of behavioral insomnia occurs when the onset of sleep is delayed in the absence of a 
certain item or circumstance. The child becomes dependent upon certain conditions being 
present during sleep onset, such as sucking on a pacifier or having another person close by. 
When the specific sleep onset conditions are met, sleep onset is quickly achieved. However, 
should the conditions not be met (i.e. the pacifier is on the floor, or mother is away) at sleep 
onset, then a struggle around getting to sleep may occur. In addition, when the child 
experiences a normal partial arousal during the night (commonly every 1-3 hours), the child 
who is used to certain conditions at bedtime will have difficulty returning to sleep if the 
conditions are no longer available. This circumstance of Behavioral Insomnia of Childhood, 
Sleep Onset Association type typically results in a night wakening and parent involvement 
to ‘correct’ or return the conditions for getting to sleep. Behavioral Insomnia of Childhood, 
Limit Setting type occurs when there are bedtime struggles. The child typically stalls or 
refuses to go to bed by requesting things such as a glass of water, or to go to the bathroom. 
When the caregiver has trouble setting and maintaining limits, the child’s sleep onset is 
delayed as a consequence. However, when such limits are set consistently, the child is able 
to sleep quickly. Many children have a mixture of Sleep Onset Association and Limit Setting 
types. As children get older, they typically have less difficulty with Sleep Onset Association 
Insomnia as they are better able to get to sleep on their own and re-create their sleep onset 
conditions and return to sleep during the night. During those same developmental stages; 
however, children are working to become more independent and are testing limits set by 
their caregivers. Often this can result in greater difficulties with Limit Setting Insomnia with 
age (Moore & Meltzer, 2008). Either type of behavioral insomnia can affect time to sleep 
onset, the continuity of nighttime sleep and the overall total amount of sleep achieved and 
therefore, the risk for daytime tiredness and associated sequelae for attention, learning and 
behavior.  
4.3.2 Delayed Sleep Onset in older children and adolescents  
4.3.2.1 Delayed Sleep Phase Syndrome 
As children move toward adolescence, they typically begin to demonstrate a circadian 
preference for a later (delayed) sleep phase. If the preference for late sleep phase becomes 
problematic and interferes with the daytime functioning of the child or adolescent, it is 
referred to as having delayed sleep phase syndrome (DSPS). DSPS is common in 
adolescence with an estimated prevalence of 10% (Moore & Meltzer, 2008). In DSPS, sleep 
onset and wake times are intractably later than socially acceptable (i.e., an adolescent who 
falls asleep at 1am, and wakes at 10am although school starts at 8am), occur at 
approximately the same time daily, and there is little or no difficulty maintaining sleep after 
sleep onset has occurred. In DSPS, the timing of the sleep-wake cycle is the problem rather 
than the quality of sleep. There are often complaints of ‘insomnia’ when the child or 
adolescent attempts to go to sleep at an early time; however not when attempting to sleep at 
a later, desired time. Typically the child or adolescent has a very difficult time waking up at 
a required time, such as for school, and has decreased alertness in the morning. This can 
lead to frequent tardiness and/or absence from school. The child or adolescent frequently 
attempts to ‘catch-up’ on lost sleep by sleeping in to the late morning or afternoon on 
weekends. DSPS can significantly shorten sleep duration, increasing the risk for daytime 
tiredness and associated sequelae.  
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4.3.2.2 Psychophysiologic insomnia  
Primary or psychophysiological insomnia can also be responsible for sleep problems in 
children and adolescents. Insomnia is broadly defined as difficulty with onset, maintenance 
or non-restorative sleep. The following consensus statement has been developed to more 
specifically define pediatric insomnia: ‘repeated difficulty with sleep initiation, duration, 
consolidation or quality that occurs despite age-appropriate time and opportunity for sleep 
and results in daytime functional impairment for the child and/or family’ (Mindell, 2010). 
Primary insomnia is characterized by tension and learned sleep-preventing associations. 
Children and adolescents with primary or psychophysiological insomnia tend to respond to 
stress with somatic symptoms, and while trying to downplay the stress, end up increasing 
the stressfulness of their insomnia. Primary insomnia is rare in pre-pubertal children, but 
has a prevalence of 9 to 13% in adolescents (Mindell, 2010).  
4.3.3 Partial arousal parasomnias 
Partial arousal parasomnias are behaviors during sleep that occur primarily related to non-
REM or slow wave sleep. These include confusional arousals, sleep walking, and sleep 
terrors. These partial arousals typically occur within a few hours of sleep onset and are 
fairly common in childhood, when the percent of non-REM sleep is greater compared to 
adulthood. Individuals with such partial arousal parasomnias do not recall the events that 
occur during sleep. Family history appears to increase the likelihood for both sleep walking 
and sleep terrors if other family members also experienced it. Confusional arousals are 
episodes where individuals are aroused but disoriented and may not fully awaken for up to 
30 minutes. These occur in at least 17% of children. Sleep walking on a regular basis is also 
common in childhood, observed in about 15 to 20%. Both confusional arousals and sleep 
walking typically begin in the preschool years. Confusional arousals tend to dissipate by 
early adolescence, whereas, for about 20% of affected individuals, sleep walking persists 
into adulthood. Sleep terrors are often more significant and distressing but primarily to the 
observer because the affected child can appear frightened and agitated. Sleep terrors occur 
in about 1 to 6% of children, with onset between preschool and preteen years and they 
typically subside by adolescence. These parasomnias can be triggered by inadequate or 
irregular sleep, illness, stress and other sleep problems such as SDB or PLMD. Parent and 
child education about the disorders, what they can do to lessen the risks for occurrence and 
assuring safety during episodes are the most important interventions. These behaviors do 
not disrupt sleep continuity on their own and therefore, uncomplicated partial arousal 
parasomnias are not typically associated with daytime behavioral sequelae like ADHD. 
However, a 2006 study from Taiwan suggested an association based on parental ratings 
(Shur-Fen Gau, 2006). In general, the presence of these parasomnias might indicate another 
sleep disorder that has been related to ADHD symptoms and might be the clue to look 
further for problems such as SDB, PLMD, or inadequate sleep.  
4.3.4 Sleep-related Rhythmic Movement Disorder 
Rhythmic movement disorder (RMD) is common in childhood, usually having onset in the 
first year of life and waning by early school age. This disorder includes various 
combinations of movements of the head, limbs, and trunk resulting in head rocking, head or 
body rolling, and head banging, among others and typically occur on transition to or from 
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sleep or during sleep. It is typical for the movements to have a regular, rhythmic pattern. To 
meet criteria for RMD, the behavior must interfere with normal sleep, impair daytime 
functioning or cause bodily injury, and not be due to another disorder or use of medication. 
Most individuals do not require treatment for RMD as the risk of injury is low and it 
dissipates with age; however, protective surfaces might be needed for more significant cases 
(Hoban, 2003). Case studies have suggested RMD in children with ADHD and ADHD in 
children with RMD but studies to date are small (Walters, 2008). 
4.3.5 Night-time fears and nightmares  
As children get older, nighttime fears and nightmares become more frequent sleeping 
problems. Most children have nighttime fears, with peak ages from 3-6 years for both sexes, 
and in girls at school-age (Moore & Meltzer, 2008). Nighttime fears are usually short-lived 
developmental phenomena and quite benign. At the peak age of nighttime fears at 
preschool-age, children are becoming more aware of the consequences of their actions and 
that they can really be hurt or affected by occurrences around them (Mindell, 2010). Typical 
nighttime fears change with developmental level, with younger children being more afraid 
of imaginary creatures such as monsters and older children being afraid of more realistic 
dangers such as a natural disaster or a burglar. Nightmares are also common in childhood, 
with approximately 75% of children experiencing at least one nightmare (Moore & Meltzer, 
2008; Mindell, 2010). Similar to nighttime fears, nightmares are a normal part of a child’s 
development, and the content tends to vary by age. Young toddlers worry about being 
separated from their parents, and as children get older they incorporate imaginary and then 
realistic fears into their nightmares. Different from nighttime fears, nightmares typically 
occur during REM sleep (usually in the last third of the sleep period when there is a greater 
percentage of REM sleep), and can be triggered by sleep deprivation. Both nighttime fears 
and nightmares can be triggered or exacerbated by stress and anxiety. Consequences of 
nighttime fears or nightmares include delayed sleep onset and prolonged night awakenings, 
respectively and either affect the degree to which sleep is restorative for the affected 
individual. 
4.3.6 Enuresis 
Sleep enuresis is another possible cause of sleep disturbance in children. Uncomplicated or 
monosymptomatic sleep enuresis is characterized by recurrent, involuntary voiding 
occurring during sleep. Enuresis can occur in any stage of sleep, although most occur in the 
first half of the night (Mindell, 2010). It, too, follows the developmental trajectory of the 
child, with a greater proportion of younger children experiencing sleep enuresis. The 
majority of sleep enuresis episodes are primary sleep enuresis, in which the child has not yet 
developed control over voiding at night, and has not had a succession of dry nights. These 
children typically fail to respond to the sensation of bladder fullness or inhibit bladder 
contractions during the night. Spontaneous remission of sleep enuresis is common as 
children age; the approximate remission rate is 15% of affected individuals per year. The 
current prevalence estimates are 30% in 4-year-olds, 10% of 6-year-olds, 5% of 10-year-olds 
and 3% of 12-year-olds. Sleep enuresis is typically not diagnosed until age 5, and not treated 
until age 7 or 8 years. Primary enuresis is more prevalent in children with a family history of 
sleep enuresis, and also, those with ADHD. Secondary enuresis, in which the child 
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previously has had control over their bladder at night (and has had a previous dry period of 
at least 6 months) and then develops sleep enuresis, does not occur as a part of typical 
development, and usually requires further diagnostic evaluation. It can be triggered by 
psychosocial stressors, medical problems such as urinary tract infections, chronic 
constipation, diabetes mellitus, a neurologic disorder, or other sleep disorders, such as 
obstructive sleep apnea or PLMD. Children with complicated or non-monosymptomatic 
sleep enuresis have day- and nighttime symptoms. 
5. Consequences of insufficient sleep  
As noted above for SDB and RLS/PLMD, poor sleep can have a great impact on daytime 
function of the child and other family members. Adults with poor sleep tend to appear tired 
during the day, yawning and falling asleep easily in inappropriate settings. However, the 
symptoms of sleepiness in children are often ‘paradoxical’ behavioral manifestations such as 
emotional lability, irritability, neurocognitive deficits and behavioral inhibition. These 
difficulties can cause problems at home, in school and in other community settings. Multiple 
parental reports (and some teacher reports) show increased incidence and severity of 
behavioral difficulties in children with sleep problems than those without (Fallone, 2002; 
Sadeh, 2002). More severe behavioral problems have been shown in children with shorter 
sleep duration (Fallone, 2002). Increased sleepiness or decreased sleep duration within the 
previous day have been associated with increased risk of accidental injury in children from 
preschool-aged through adolescence (Fallone, 2002). Insufficient sleep and/or sleepiness in 
adolescents have been associated with increased risk-taking behaviors (Moore & Meltzer, 
2008). Children with behavior problems are also more likely to have sleep problems by 
parental report (Fallone, 2002). Studies have shown improvement in these behavioral 
problems with improved sleep; however, not across all settings (Fallone, 2002). Lower 
academic achievement has also been associated with poor sleep in children, when compared 
to children with unimpaired sleep (Fallone, 2002). Additionally, adolescents who reported 
poor sleep were more likely to report social problems as well (Owens, 2008). An association 
between acute sleep restriction and poorer memory or lower IQ has not been found (Fallone, 
2002; O’Brien, 2004). However, longer-term sleep disturbance has been linked to impaired 
memory and intelligence (O’Brien, 2004). 
Children’s sleep problems can also cause a significant amount of distress in the family. The 
impact of childhood sleep problems is related to the parents’ sleep, especially if the parents’ 
poor sleep leads to daytime fatigue or mood problems (O’Brien, 2004). Alternatively, 
improving the child’s sleep, and by extension that of the rest of the family, can improve the 
functioning of all family members involved.  
6. Sleep in children with ADHD  
As noted previously in this chapter, sleep difficulties were part of the diagnostic criteria for 
ADHD in previous versions of the Diagnostic Statistical Manual, indicating a long-standing 
belief that sleep is problematic in children with ADHD. However, although the relationship 
between sleep and ADHD has been studied extensively over the past few decades very few 
objective differences have been found between the sleep of children with ADHD and 
children without ADHD. Yet, many subjective differences have been uncovered.  
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6.1 Sleep and ADHD: subjective differences 
There is little disagreement in the literature that parents of children with ADHD report 
poorer sleep for their children than parents of children without ADHD. O’Brien et. al found 
that 77% of children with significant symptoms of ADHD, and 70% of children with mild 
symptoms of ADHD were reported to have sleep disturbances while only 43% of children 
without ADHD symptoms were reported to have sleep problems (O’Brien, 2003). Parents of 
children with ADHD report more of the following than parents of children without ADHD: 
bedtime resistance; sleep-onset delay; anxiety; parasomnias; night wakings; daytime 
sleepiness; and shorter duration of sleep (Owens, 2000; Corkum, 2001; O’Brien, 2003; 
Silvestri et al., 2009; Gruber, 2009). Parents also report more snoring in children with ADHD 
compared with controls (Cortese, 2009). Children with and without ADHD tend to have 
morning arousal at the same time, but children with ADHD have a shorter reported sleep 
duration thought to be due to delayed sleep onset (Owens, 2005). 
There are several possible explanations for these increased subjective complaints in children 
with ADHD. One hypothesis suggests that some of these are not sleeping problems per se, 
rather, behavioral problems in the context of a difficult parent-child relationship (Cortese, 
2009; Corkum, 2001). Another hypothesis is that families of children with ADHD are more 
likely to have poor sleep hygiene (i.e., bedtime routines, sleeping environment), leading to 
more difficulties at bedtime (Cortese, 2009). Alternatively, children with ADHD may have 
symptoms throughout the day and evening, which creates bedtime difficulties even in the 
appropriate environment (Cortese, 2009; Gruber, 2009). Some children with ADHD may 
have a disorder of their sleep-wake schedule (i.e., delayed sleep phase syndrome or other 
disorder of circadian rhythm), and aren’t able to fall asleep when they are expected to, 
which can lead to bedtime resistance (Gruber, 2009). Children with ADHD may also have 
co-morbid psychiatric disorders which contribute to bedtime difficulties (see below). Owens 
et. al found that parents of children with ADHD recognize sleep-onset difficulties as 
different from bedtime refusal. Other studies have drawn similar conclusions; parents are 
able to recognize the difference between unwillingness and inability to sleep (Blader et al., 
1997). Stimulant medication is frequently used to treat ADHD in children and may have 
effects on their sleep. This will be addressed in a later section of this chapter.  
6.2 Sleep and ADHD: objective differences 
There is little agreement in the literature regarding objective differences in sleep in children 
with ADHD. Sleep in children with ADHD has been frequently studied but with small 
populations, and with conflicting results. Higher rates of obstructive sleep apnea (higher 
apnea-hypopnea index) have been found in children with ADHD (O’Brien, 2003; Cortese, 
2009; Golan, 2004). Children with mild symptoms of ADHD are more likely to have 
obstructive sleep apnea than those with significant or no symptoms (O’Brien, 2003). 
Children with ADHD have also been found to have an increased REM latency and smaller 
percentage of sleep spent in REM (O’Brien, 2003, 2003; Silvestri et al., 2009; Busby, 1981). 
O’Brien et al found a positive correlation between length of REM latency and impulsivity, 
inattention, cognition and hyperactive behaviors, and a negative correlation between REM 
latency and attention and executive functioning (O’Brien, 2003). Yet, other studies have 
shown an increase in percentage of REM sleep in children with ADHD (Golan, 2004) or 
decreased REM latency (Khan, 1982; Kirov et al., 2004), and still others have shown no 
differences in REM latency or percentage (Golan, 2004; Cortese, 2009). Increased periodic 
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limb movements have been discovered in children with ADHD (Busby, 1981; O’Brien, 2003; 
Silvestri et al., 2009). Others have found decreased sleep efficiency, increased arousal index 
and increased daytime sleepiness in children with ADHD (Goraya et al., 2009; Cortese, 2009; 
O’Brien, 2003; Silvestri et al., 2009; Gruber, 2009; Golan, 2004). The hyperactivity in children 
with ADHD has been hypothesized as a compensatory mechanism for the increased 
daytime sleepiness related to poor duration and/or quality sleep. Despite these many 
studies, there is much more to be discovered concerning the sleep of children with ADHD.  
One theory which addresses these conflicting differences in the sleep of children with 
ADHD is that there are different subsets of ADHD, some of which are associated with more 
sleeping problems. O’Brien et. al compared the sleep of children with ADHD referred to 
their sleep clinic, children with ADHD symptoms from the community and children 
without ADHD, and found that while all children with ADHD had some differences 
compared to the controls, the children who were referred also had greater nightmares, 
enuresis and witnessed apneas compared to the children with ADHD symptoms from the 
community group (O’Brien, 2003). They proposed that the children who were referred 
represent a different subset of children with ADHD. Additionally, differences have been 
found, in some cases, between the sleep of children with ADHD inattentive subtype and 
combined subtype, with more differences in sleeping patterns found between children with 
combined subtype ADHD and typically developing children (Gruber, 2009; Mayes, 2009).  
Co-morbid psychiatric disorders are common in children with ADHD, and are thought to 
contribute to problems with sleep. Children with ADHD and anxiety or depression were 
found to have more sleeping problems than those without, although children with co-
morbid oppositional defiant disorder (ODD) were not found to have increased sleeping 
problems (Mayes, 2009). Sleep problems have been shown to have a weaker relationship 
with ADHD after controlling for co-morbid anxiety, depression or disruptive behavior 
disorders (Mick, 2000). However, some of the studies previously discussed in this section 
found differences in sleep in children with ADHD without co-morbid psychiatric disorders 
compared to typically developing children.  
7. Medical treatment for ADHD and sleep problems  
7.1 Psychostimulant medications for ADHD and effects on sleep 
Psychostimulant medication, the first–line treatment for ADHD, has often been cited as 
causing sleeping disturbances in this population. However, as discussed in previous 
sections, there is a complicated relationship between ADHD and sleep. Some have 
suggested that stimulant medication causes sleep disturbances in children and adolescents 
with ADHD. Some studies of stimulant medication have supported this, but others have 
shown no change or improvements in sleep in children and adolescents treated with 
psychostimulant medication, (Galland et al., 2010; Mick, 2000; Barkley et al., 1990; Giordani, 
2008; O’Brien, 2003; Kim, 2010; Giblin & Strobel, 2010). 
Regarding studies where the use of psychostimulant medication has been associated with 
poor sleep, in a study by Mick et. al, there was a trend towards children with ADHD having 
more sleep disorders and when multiple confounding variables were accounted for, they 
found a relationship between the use of stimulant medication and poor sleep (Mick, 2000). 
Children with ADHD treated with psychostimulant medication were more likely than 
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controls to be reported as a restless sleeper, waking during the night, talking in their sleep, 
afraid of sleeping in the dark and going to the bathroom during the night (Mick, 2000). 
Parents have also reported more difficulty with insomnia in children with ADHD treated 
with psychostimulants (Barkley et al., 1990). Several objective studies have also shown 
changes in sleep with psychostimulant medication. EEG studies have shown increased REM 
onset latency and of stage 1 and 2 sleep with a resultant decrease in time spent in REM and 
stage 3 sleep after nocturnal administration of a psychostimulant (Chatoor, 1983). 
Polysomnography studies showed no significant difference in sleep timing, duration or 
efficacy between children with ADHD off of medication for 48 hours and control children 
(Galland et al., 2010). However, when the children with ADHD had taken their dose of 
psychostimulant medication, they had a longer sleep latency and woke earlier in the 
morning, resulting in a shorter sleep duration in comparison to control children (Galland et 
al., 2010). Sleep architecture was not altered by the medication (Galland et al., 2010). Galland 
et. al observed that their study, and others that had found increased sleep onset latency on 
psychostimulant treatment, were designed such that the comparisons between 
methylphenidate and placebo were within-subject. They postulate that this may indicate 
that the individual differences of the effects of psychostimulant medication on sleep may be 
more important than larger group differences (Galland et al., 2010).  
Another hypothesized factor is that the increased reported difficulties with sleep in children 
with ADHD treated with psychostimulant medication may be the result of the 
psychostimulant medication wearing off and/or causing a ‘rebound’ effect. This rebound 
effect can lead to an apparent increased arousal and hyperactivity. This led to the idea that 
some children may benefit from an additional late afternoon or early evening dose of 
psychostimulant medication. An additional late afternoon (4pm) dose was shown to 
improve behavior in 12 psychiatrically hospitalized children with ADHD (Kent et al., 1995). 
Low-dose (10mg) and high-dose (15mg) methylphenidate and placebo were given at 4pm, 
with little effect on the sleep onset in the children (Kent et al., 1995). When receiving the 
high-dose methylphenidate, children did have an increased sleep onset latency (Kent et al., 
1995). Notably, the increased sleep onset latency in children on the higher dose of 
methylphenidate was similar to that of children on the placebo (Kent et al., 1995). A similar 
study tested the effect of twice-daily dosing to thrice-daily dosing of methylphenidate in 
children with ADHD, and found that there were no differences in sleep duration between 
the two dosing regimens (Stein, 2001). However, there was a trend toward decreased sleep 
duration in the thrice-daily dosing compared to placebo on parental ratings and actigraphic 
measurements (Stein, 2001). Sleep onset latency did not differ significantly across the dosing 
protocols (including placebo) (Stein, 2001).  
Other recent studies, have confirmed the relationship of ADHD with poor sleep, but 
demonstrated little association psychostimulant medication to poorer sleep in children with 
ADHD. Children with ADHD were found to have more sleep disturbances than those 
without ADHD, irrespective of their medication status (O’Brien, 2003). The use of 
psychostimulant medication was not found to have an association with poor sleep (O’Brien, 
2003). Children with ADHD treated with psychostimulant medication tended to have longer 
REM onset latency, however this did not reach statistical significance (O’Brien, 2003).  
Increased sleep disturbances have not been found in children treated with sustained release 
preparations of psychostimulants (Kim, 2010; Giblin & Strobel, 2010). Osmotic-controlled 
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release oral delivery system (OROS) methylphenidate was found to decrease the number of 
night arousals (parasomnias) in children with ADHD, but not alter sleep onset latency on 
either subjective or objective measures (Kim, 2010) . However, children who reported 
subjective sleep difficulties during treatment with OROS methylphenidate had increased 
sleep onset latency, sleep onset delay and bedtime resistance when compared to those 
without subjective sleep complaints. This again, may indicate that the individual’s response 
to stimulant medication may be the most important factor (Kim, 2010). Lisdexamfetamine 
was also shown to decrease nighttime arousals, and did not negatively impact sleep in 
children with ADHD (Giblin & Strobel 2010). The decreased nighttime arousals may suggest 
more consolidated sleep in children treated with psychostimulants.  
Therefore, the use of psychostimulant medications has been associated with poor sleep in 
children with ADHD in some studies; however the exact relationship remains unclear. 
Individuals with sleep complaints while on psychostimulant medications have been noted 
to have increased sleep disturbance. Perhaps it is best to consider each patient individually 
when assessing for adverse effects of treatment. It may be that for the majority of patients, 
treatment with psychostimulant medication does not interfere with sleep, but in those 
reporting worse sleep, the medication does play a role in sleep disturbances.  
7.2 Non-psychostimulant Medications for ADHD and effects on sleep 
In 2002, the US Food & Drug Administration (FDA) approved the non-stimulant, 
atomoxetine for use in children with ADHD. Greater clinical improvement is typically 
attained with psychostimulant medication; however atomoxetine can be good alternative 
medication to use when a psychostimulant medication is not tolerated or cannot be used 
(Newcorn et al., 2008). When compared with thrice-daily dosing of methylphenidate, twice-
daily atomoxetine was found to have decreased sleep onset latency, and increased sleep 
duration (Sangal, 2004). Treatment with twice-daily atomoxetine and thrice-daily 
methylphenidate resulted in decreased interrupted sleep; however, treatment with 
methylphenidate led to a larger decrease in interrupted sleep (Sangal, 2004). Children 
reported an easier time awakening in the mornings and falling asleep at night while taking 
atomoxetine (Sangal, 2004). The most common sleep-related adverse effect reported from 
atomoxetine is somnolence (Kratochvil et al., 2011; Cheng et al., 2007; Newcorn et al., 2008). 
Alpha-agonists such a clonidine and guanfacine have been used to treat both the behavioral 
and sleep problems of ADHD. Clonidine has been helpful in treating sleeping problems in 
children with ADHD (Plizka, 2007). Trials of long acting clonidine (with and without the use 
of psychostimulants) have shown that somnolence and/or fatigue are the major sleep-
related adverse effect of treatment (Biederman et al., 2008; Kollins et al., 2011). However, 
Biederman et. al showed that this is usually a transient effect (Biederman et al., 2008).  
7.3 Medications for sleep problems in children with ADHD  
As discussed extensively in this chapter, sleeping disturbances are frequently associated 
with ADHD. Some of these sleep disturbances can be related to anatomic disorders, such as 
sleep-disordered breathing or perhaps an adverse effect of psychostimulant medication. 
However, in many cases, a modifiable cause is not identified that results in a medical 
treatment for the sleep disturbance. In fact, a large Netherlands study of children with 
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ADHD on stimulant medication found that over 10% of the children were taking melatonin, 
presumably for sleep problems (Faber et al., 2006). Melatonin has been shown to decrease 
sleep onset latency in children with ADHD (not on medication) with chronic sleep-onset 
insomnia (Van der Heijden et al., 2006). Despite this improved sleep onset latency, there was 
not significant effect (positive or negative) on the children’s behavior, cognition or quality of 
life (Van der Heijden et al., 2006). In follow-up of this study, approximately 3 years later, the 
majority of children remained on melatonin, and their parents thought it was an effective 
treatment (Hoebert et al., 2009). Parents reported that the melatonin improved their 
children’s daytime behavior (Hoebert et al., 2009). A literature review confirmed that 
children with ADHD and insomnia showed improvement in regards to sleep onset latency 
when taking melatonin (Bendz & Scates, 2010). However, these results are limited as there 
are few studies, and most of them have small sample sizes. Zolpidem has also been 
evaluated for treating sleep disturbances in children and adolescents with ADHD (Blumer et 
al., 2009). Zolpidem did not decrease sleep onset latency, nor improve sleep efficiency or 
nocturnal awakenings (Blumer et al., 2009). There was a trend toward improving behavioral 
symptoms, particularly in the adolescents; however, this did not reach statistical significance 
(Blumer et al., 2009).  
8. Clinical application 
In this section, we describe two clinical cases examples where ADHD evaluation might be 
complicated by sleep concerns. The purpose is to highlight several concepts regarding 
development and sleep.  
8.1 Younger child  
Alex, a 7-year-old boy, presented to his primary care physician’s office with his mother due 
to problematic behavior at school. His mother notes that he’s always been a busy and active 
child. Over the past few years, she’s had some difficulty with his behavior at home, noting 
that he had frequent temper tantrums as a toddler and preschool-aged child, but the parents 
thought his behavior was manageable. However, last year in kindergarten Alex’s teacher 
also expressed concern about his behavior and this has increased with his first grade teacher 
this year. He has been having difficulty staying seated with the rest of his class during story 
time and with staying in line with his class when they leave the classroom. He has also 
recently hit a classmate over a minor disagreement. He typically gets along with other 
children, and mother notes that he has two best friends, with whom he likes to ride bikes. 
There was no history of problems at birth or with development. He has no chronic medical 
concerns, has not had hospitalization or surgery and has not had significant injuries. He is 
involved in Boy Scouts and sports outside of school.  
On review of systems, Alex’s mother notes that his sleep schedule is typically uniform 
throughout the week. He goes to bed around 8 PM on weeknights, and wakes up at 7 AM 
for school. On the weekends, he tends to go to bed around 8:30 PM, and wakes at 7 AM on 
his own. He tends to fall asleep approximately 30-45 minutes after his bedtime. He does not 
appear tired in the morning or throughout the day, and does not nap, nor fall asleep 
unintentionally. His mother does struggle to put him to bed most nights, noting that he 
seems “to do anything to avoid sleeping”. He frequently asks for another story, and glass of 
water. Alex’s mother also notes that he snores quite loudly; she can hear him snoring from 
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her bedroom when his door is closed. She hasn’t noted any pauses in breathing. He sweats 
during sleep frequently, requiring his mother to change the sheets during the night 
approximately once a week. He has been dry at night for the past three months, and prior to 
that he had sleep enuresis approximately once every two weeks. Alex’s mother and older 
brother have ADHD, and his maternal grandfather was recently diagnosed with obstructive 
sleep apnea. He does not have any family history of learning disability or mood disorder. 
His physical exam was notable for mouth breathing and 3+ tonsils. 
Alex’s sleep concerns raise questions about multiple sleep problems. One such problem is 
sleep disordered breathing, common in early school-age children. Alex is at a peak age for 
increased lymphoid hypertrophy, which can cause a relative narrowing of the airway 
during sleep. His bedtime resistance could suggest behavioral insomnia of childhood, limit 
setting type, with inadequate limit-setting by his mother or his negative behavior may be 
the result of tiredness made worse by the poor quality sleep due to sleep disordered 
breathing. Alex’s duration of sleep is likely appropriate for his age; however the quality is 
likely disturbed and affecting his daytime functioning.  
To evaluate further, an overnight polysomnography was performed, which demonstrated 
obstructive sleep apnea. Conners rating scales from both parents and his first grade teacher 
endorsed problems with attention, hyperactivity and impulsivity for age and gender. 
Alex was evaluated by a pediatric otolaryngologist who recommended an adenotonsillectomy, 
which was subsequently performed. Three months after his surgery, Alex’s mother noted 
significant improvements in his snoring, now only infrequently and that he no longer sweats 
at night, and has remained dry overnight. However, he has remained very active and ‘on the 
go’ and while his behavior problems at school had improved somewhat, he continued to have 
difficulties. His primary physician initiated a trial of short-acting stimulant medication, to 
which Alex responded quite well. Alex’s presenting concerns seemed to be related to both his 
sleep problems and underlying ADHD. 
8.2 Early adolescent  
Susie, a 13-year-old female, presents to her primary doctor accompanied by her mother for 
concerns regarding poor school performance. Mother states Susie has had longer term 
concerns about being fidgety and distractible but had always been able to keep pace with 
her peers until 7th grade. There were no academic concerns in elementary school and grades 
continued to be adequate, although in retrospect, drifted downward in 6th grade. In 7th 
grade she had more trouble; she forgot to turn in assignments, seemed disorganized and 
didn’t follow through on directions at school, as well as, at home. In 8th grade this year, she 
is close to failing. Teachers state her test performance has been good, but the frequently 
missing assignments and little engagement in classroom discussions have pulled down her 
grades. In addition, they report she has been prone to napping in the first-hour math class. 
There is no history of problems at birth or with development. She has no chronic medical 
concerns and has not had significant injuries. She started menses at about 10 years of age. 
She is active with sports and music for school, participating in swimming and playing cello 
throughout the year. Her group of friends has been stable. She describes a very busy school 
schedule and that she is concerned about doing well. 
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On review of systems, Susie states that on weekends, she typically goes to sleep about 
midnight and will get up about 10 to 11 AM on her own. During the school week, she tries 
to go to bed at 10 PM but “can’t get to sleep for hours”. She needs to be up by 6 AM for 
school. She describes feeling uncomfortable at sleep onset due to her legs feeling restless and 
thinking about the next school day. Mother has not had concerns about Susie snoring nor 
mouth breathing in the past. She recently slept in the same room on a vacation and did not 
hear audible mouth breathing but did notice that Susie seemed to toss a turn quite a bit 
during sleep. Susie had occasional sleep walking when younger but not in the last four 
years. Susie and her family are vegetarian and she doesn’t usually take vitamins. Paternal 
family members have had ADHD and restless legs but no history of learning disability, 
anxiety or sleep disordered breathing. There were no significant physical exam findings. 
Susie’s sleep concerns raise a question about several sleep problems. One is delayed sleep 
phase syndrome, a common tendency among adolescents for the sleep-wake schedule to 
drift later. Susie’s later sleep–wake cycle, when coupled with her school schedule, increases 
the risk for problems with sleep initiation and getting up in time for school. Her restlessness 
at bedtime and through the night, as well as the sensations at the lower extremities at 
bedtime suggest restless legs syndrome. She is at risk for iron deficiency, associated with 
RLS/PLMD, due to the less dietary iron, growth due to adolescence and losses due to early 
menarche. In addition, Susie’s worries about doing well may add to her risk for insomnia. 
Altogether, Susie’s duration and quality of sleep are likely disturbed and in turn, affecting 
daytime functioning through potentially direct effects related to RLS and indirectly through 
chronic sleep deprivation. Her daytime sleepiness is an indication that the sleep she is 
getting isn’t enough. The parent has had a long-standing concern about some ADHD 
symptoms but the onset is later than typical.  
To evaluate Susie further, a sleep log was obtained to assess sleep duration and the stability 
of sleep-wake pattern. Iron studies were obtained and showed a serum ferritin of 10, 
borderline low serum iron but no anemia. Conners rating scales from both parents and two 
teachers endorsed problems with attention and executive functioning but all other scales 
(including hyperactive-impulsive domains) were within normal limits for age and gender.  
Susie was recommended to begin an iron supplement for the mild iron deficiency. In 
addition, Susie worked with the doctor to regularize her sleep-wake schedule between 
weekday and weekend. Susie also adjusted her daytime schedule so that she felt better able 
to meet her commitments for school, homework, practice times and friends. After three to 
four months, repeat iron studies showed correction of iron status and improved RLS 
symptoms. She was adhering to the new schedule and getting to sleep more easily. Conners 
rating scales and interview at follow up did not endorse ADHD concerns and teachers 
reported improved school performance. Taken together, Susie’s presenting concerns seemed 
more likely related to sleep problems than ADHD at this time, but longer term follow up 
was recommended to assure she remained on track. 
9. Conclusion 
In this chapter, we have reviewed the relationship between ADHD and sleep disorders with 
the purpose of highlighting the importance of evaluating sleep problems when children and 
adolescents present for evaluation of ADHD. Studies have suggested that many 
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practitioners do not routinely screen for sleep problems in general or for specific conditions 
like SDB in particular (Chervin, 2000; Chervin, 2001; Blunden, 2004). In one study in a 
general pediatric clinic, 830 parents of children ages two to thirteen years of age completed 
the Pediatric Sleep Questionnaire (PSQ), a validated survey of a number of medical and 
behavioral problems of sleep in children (Chervin, 2000). The parents of 86 children 
endorsed a sleep problem for their child and 44 of them (about 5% of the total number) 
endorsed symptoms of sleep disordered breathing. On a retrospective chart review of these 
children, less than 11% (5 of 44) had documentation that the symptoms were discussed 
(Chervin, 2001). Other studies have also called attention to the importance of screening 











Does your child have 
any problems going to 
bed? Falling asleep? 
Does your child have any 
problems at bedtime? 
(Parent) Do you have any 
problems going to bed? 
(Child) 
Do you have any 
problems falling 





Does your child seem 
overtired or sleepy a lot 
during the day? Does 
she still take naps? 
Does your child have 
difficulty waking in the 
morning, seem sleepy 
during the day or take 
haps? (Parent) Do you feel 
tired a lot? (Child) 
Do you feel sleep a 
lot during the day? 





Does your child wake 
up a lot at night? 
Does your child seem to 
wake up a lot at night? 
Any sleepwalking or 
nightmares? (Parent) Do 
you wake up a lot at 
night? Have trouble 
getting back to sleep? 
(Child) 
Do you wake up a 
lot at night? Have 
trouble getting back 




Does your child have a 
regular bedtime and 
wake time? What are 
they? 
What time does your child 
go to bed and get up on 
school days? Weekends? 
Do you think he/she is 
getting enough sleep? 
(Parent) 
What time do you 
usually go to bed on 
school nights? 
Weekends? How 
much sleep do you 
usually get? (Child) 
5. Snoring 
Does your child snore a 
lot or have difficulty 
breathing at night? 
Does your child have loud 
or nightly snoring or any 
breathing difficulties at 
night? (Parent) 
Does your teenager 
snore loudly or 
nightly? (Parent) 
Source: Owens, J. and Dalzell, V. “Use of the ‘BEARS’ sleep screening tool in a pediatric continuity 
clinic: a pilot study.” Sleep Medicine: 6 (2005) 63-69, used with permission 
Table 1. BEARS Sleep Screening Algorithm  
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A screening tool, the BEARS was developed by Owens et. al., and consists of five sleep-
related areas to screen at primary care visits. After implementing this instrument in a 
primary care setting, significantly more sleep issues were documented and sleep problems 
identified by the practitioners (Owens & Dalzell, 2005).  
The term “BEARS” stands for:  
 B - Bedtime problems 
 E - Excessive daytime sleepiness 
 A - Awakenings during the night 
 R - Regularity of sleep/wake cycles and average sleep duration 
 S – Snoring 
In conclusion, the relationship between ADHD and sleep disorders in children and 
adolescents can make evaluation of ADHD challenging. However, a methodical and 
thorough evaluation that recognizes expected and unexpected developmental features 
related to sleep will help to assure proper and timely identification and management of both 
ADHD and disorders of sleep.  
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